Laura Erwin is a highly resourceful regulatory affairs and medical writing consultant, currently serving as a Senior Regulatory and Medical Writer at Boyds. Previously, Laura was a postdoctoral fellow in psychiatry at Harvard University and held various roles, including regulatory scientist at Allucent and clinical strategy scientist at CATO SMS. With an educational foundation that includes a PhD in Pharmacology from Louisiana State University Health Sciences Center and a bachelor's degree in Microbiology, Laura has garnered extensive research experience in preclinical pharmacology. Their background in both regulatory consulting and strategic planning has equipped them to develop effective clinical trial management plans and product development strategies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices